Market research
RKT.LSE Reckitt Benckiser Group plc
LSE GBP Consumer Defensive
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 35B
- P/E ratio
- 12.58
- Analyst target
- 6286.421
- Dividend yield
- 3.9%
- Beta
- 0.28
Profile
Instrument facts
- Exchange
- LSE
- Currency
- GBP
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- ISIN
- GB00BSZBP530
- Market cap
- 35B
- P/E ratio
- 12.58
- Analyst target
- 6286.421
- Dividend yield
- 3.9%
- Beta
- 0.28
About
About Reckitt Benckiser Group plc
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under MegaRed, Airborne, Digestive-Advantage, Movefree, and neuriva names; stain removal under Vanish brand name; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.
Research context
Reckitt Benckiser Group plc appears in PyInvesting’s London Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- GBP
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
0 comments
Sign in to join the RKT.LSE discussion.
No comments yet
Start a focused discussion about RKT.LSE.